VitaNova Life Sciences Corporation Increase (Decrease) in Accounts Receivable
VitaNova Life Sciences Corporation (VNOV) reported Increase (Decrease) in Accounts Receivable of -$409.87 thousand for the 3-month period ending 2026-07-31, per its 10-Q filed 2026-09-14.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccountsReceivable · last filed 2026-09-14
- VitaNova Life Sciences Corporation increase (decrease) in accounts receivable for the quarter ending 2026-07-31 was -$409.87K.
- VitaNova Life Sciences Corporation increase (decrease) in accounts receivable for the quarter ending 2026-04-30 was -$216.33K, a 117.84% decline year-over-year.
- VitaNova Life Sciences Corporation increase (decrease) in accounts receivable for the quarter ending 2026-01-31 was $121.83K.
- VitaNova Life Sciences Corporation increase (decrease) in accounts receivable for the quarter ending 2025-10-31 was -$131.67K, a 328.20% decline year-over-year.
- VitaNova Life Sciences Corporation increase (decrease) in accounts receivable for fiscal 2026 was -$478.84K, a 137.79% decline from fiscal 2025.
- VitaNova Life Sciences Corporation increase (decrease) in accounts receivable for fiscal 2025 was $1.27M.
- VitaNova Life Sciences Corporation increase (decrease) in accounts receivable for fiscal 2024 was $0.00.
| Period end | Increase (Decrease) in Accounts Receivable 3 month | Increase (Decrease) in Accounts Receivable 6 month | Increase (Decrease) in Accounts Receivable 9 month | Increase (Decrease) in Accounts Receivable 12 month |
|---|---|---|---|---|
| 2026-07-31 | -$409.87K 10-Q · filed 2026-09-14 | -$626.21K derived: sum of 2 quarters · filed 2026-09-14 | -$504.38K derived: sum of 3 quarters · filed 2026-09-14 | -$636.04K derived: sum of 4 quarters · filed 2026-09-14 |
| 2026-04-30 | -$216.33K derived: 10-K 12 month − 10-Q 9 month · filed 2026-07-29 | -$94.50K derived: sum of 2 quarters · filed 2026-07-29 | -$226.17K derived: sum of 3 quarters · filed 2026-07-29 | -$478.84K 10-K · filed 2026-07-29 |
| 2026-01-31 | $121.83K derived: 10-Q 9 month − 10-Q 6 month · filed 2026-03-16 | -$9.84K derived: sum of 2 quarters · filed 2026-03-16 | -$262.51K 10-Q · filed 2026-03-16 | $950.42K derived: sum of 4 quarters · filed 2026-09-14 |
| 2025-10-31 | -$131.67K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-12-15 | -$384.34K 10-Q · filed 2025-12-15 | $828.59K derived: sum of 3 quarters · filed 2026-09-14 | $824.91K derived: sum of 4 quarters · filed 2026-09-14 |
| 2025-07-31 | -$252.67K 10-Q · filed 2026-09-14 | $960.26K derived: sum of 2 quarters · filed 2026-09-14 | $956.58K derived: sum of 3 quarters · filed 2026-09-14 | $1.01M derived: sum of 4 quarters · filed 2026-09-14 |
| 2025-04-30 | $1.21M derived: 10-K 12 month − 10-Q 9 month · filed 2026-07-29 | $1.21M derived: sum of 2 quarters · filed 2026-07-29 | $1.27M derived: sum of 3 quarters · filed 2026-07-29 | $1.27M 10-K · filed 2026-07-29 |
| 2025-01-31 | -$3.68K derived: 10-Q 9 month − 10-Q 6 month · filed 2026-03-16 | $54.02K derived: sum of 2 quarters · filed 2026-03-16 | $54.02K 10-Q · filed 2026-03-16 | $54.02K derived: sum of 4 quarters · filed 2026-03-16 |
| 2024-10-31 | $57.70K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-12-15 | $57.70K 10-Q · filed 2025-12-15 | $57.70K derived: sum of 3 quarters · filed 2025-12-15 | $57.70K derived: sum of 4 quarters · filed 2025-12-15 |
| 2024-07-31 | $0.00 10-Q · filed 2025-09-12 | $0.00 derived: sum of 2 quarters · filed 2025-09-12 | $0.00 derived: sum of 3 quarters · filed 2025-09-12 | |
| 2024-04-30 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-07-24 | $0.00 derived: sum of 2 quarters · filed 2025-07-24 | $0.00 10-K · filed 2025-07-24 | |
| 2024-01-31 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-03-17 | $0.00 10-Q · filed 2025-03-17 | ||
| 2023-10-31 | $0.00 10-Q · filed 2024-12-13 |